Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
AssigneePhylogica Limited
InventorsPaul M. Watt, Richard Hopkins, Mark Fear, Nadia M. D. Milech
Life of this patent
Estimating the term…
Loading patent…
AssigneePhylogica Limited
InventorsPaul M. Watt, Richard Hopkins, Mark Fear, Nadia M. D. Milech
Estimating the term…
The present invention provides a non-hybrid screening method for the identification and/or isolation of a peptide that is capable of modulating a phenotype in a cell, tissue or organism. For example, the non-hybrid screening method identifies a peptide that is derived from an organism that is unrelated to the cell, tissue or organism. Alternatively, or in addition, the non-hybrid screening method identifies a peptide that is capable of rescuing the cell, tissue or organism from cell death or inducing a cell, tissue or organism to grow. The present invention also provides a non-hybrid screening method for identifying a peptide that is useful for treating a disease and/or disorder.
A non-hybrid screening method for identifying a peptide capable of modulating a phenotype in a cell, tissue or organism, said method comprising:
A non-hybrid method for identifying a peptide capable of modulating a phenotype in a cell, tissue or organism, said method comprising:
25-33. (canceled)
-45. (canceled)
The method according to 46 wherein the candidate peptide that mimics the structure of a domain or subdomain of a protein is encoded by a nucleic acid fragment from about 10 nucleotides in length to about 200 nucleotides in length.
A method for identifying a peptide capable of inducing cell growth on a cell that is dependent on the presence of a cytokine for cell growth, said method comprising:
A method for identifying a peptide capable of inhibiting cell death induced by expression of Aurora-A kinase in a yeast cell, said method comprising:
A method for identifying a peptide capable of inhibiting cell death induced by expression of cyclin-E in a yeast cell, said method comprising:
An expression library comprising nucleic acid fragments derived from two or more microorganisms selected from the group consisting of Archaeoglobus fulgidus, Aquifex aeolicus, Aeropyrum pernix, Bacillus subtilis, Bordetella pertussis, Borrelia burgdorferi, Chlamydia trachomatis, Escherichia coli K12, Haemophilus influenzae, Helicobacter pylori, Methanobacterium thermoautotrophicum, Methanococcus jannashii, Neisseria meningitidis, Pyrococcus horikoshii, Pseudomonas aeruginosa, Synechocystis PCC 6803, Thermoplasma volcanicum, Thermotoga maritima, Acidobacterium capsulatum, Halobacterium salinarum, Desulfobacterium autotrophicum, Haloferax volcanii, Rhodopirellula baltica, Thermus thermophilus HB27 and Prochlorococcus marinus MED4, and wherein the nucleic acid fragments are inserted into an expression vector thereby producing recombinant constructs wherein each fragment is in operable connection with a promoter sequence that is capable of conferring expression of that fragment.
(canceled)
Dependencies are inferred from the claim text.